Vigila – pharmacovigilance in community pharmacy

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: MARTIN GUTIERREZ, Laura (General Pharmaceutical Council of Spain, Madrid, Spain)
  • Co-author(s): Jesus Aguilar Santamaria: Presidency, General Pharmaceutical Council of Spain, Madrid, Spain
    Luis Amaro Cendon: Secretary General, General Pharmaceutical Council of Spain, Madrid, Spain
    Rosa Lopez-Torres Hidalgo: Treasury, General Pharmaceutical Council of Spain, Madrid, Spain
    Carmen Recio Jaraba: Technical Director, General Pharmaceutical Council of Spain, Madrid, Spain
    Carmen Megia Arias: Professional Development, General Pharmaceutical Council of Spain, Madrid, Spain
    Raquel Varas Doval: Professional Development, General Pharmaceutical Council of Spain, Madrid, Spain
    Laura Martin Gutierrez: Professional Development, General Pharmaceutical Council of Spain, Madrid, Spain
  • Abstract:

    Background

    Pharmacists are key healthcare professionals for a safe and effective use of medicines by patients. Nevertheless, all medicines can produce undesired effects, which may compromise the safety of the pharmacotherapy. Detecting their occurrence and offering information and assistance to patients are some of the roles of pharmacists.

    Purpose

    VI

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login